Category: pharma & healthcare

This is the second story on how a novel aspect of the APOE4 genetic predisposition to Alzheimer’s was recently uncovered by a team at MIT and may lead to the potential for new diagnostic methods and treatments.

In the wake of a wave of protests that gripped numerous Chinese cities last month, the Beijing government relaxed its strict Covid-19 restrictions. Emerging evidence suggests a massive surge in Covid-19 infections has ensued, with a corresponding steep…

NHS England is substantially scaling up whole genome sequencing in a population-wide effort. In an ambitious program, beginning in 2023, all seriously ill children in England with an unexplained disorder will be eligible for genome analysis, which invo…

Rising STD infections led to the French decision to facilitate free access to condoms and STD tests in the 18 to 25 age group. And, the French are widening free access to hormonal contraceptives.

A growing body of research suggests giving the immune system more time to “learn” about a vaccine antigen improves immune memory, helping to keep us safe during reinfection.

Regardless of what happens to the price of Paxlovid once the product is commercialized, a uniquely American situation will emerge in which a person’s access to a potentially life-saving Covid-19 treatment will depend on arbitrary features like insuranc…

In a world where fat is added to nearly every meal, the challenge many Americans face is how to cap their daily fat intake. Now, in a recent study, investigators argue that restricting fat cravings may be outside our conscious control.

A new study reveals the integral role of spike conformation on neutralizing activity in vaccines, paving the way for advancements in the near future.

A recent CDC report notes that people over the age of 80 are less likely to receive Paxlovid than those under 65. A significant issue when those over 65 and especially those over 80 are making up a significant proportion of Covid-19 related deaths.